Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 497833-27-9
2. Itf2357
3. Givinostat [inn]
4. Givinostat Free Base
5. Itf-2357
6. [6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate
7. 5p60f84fbh
8. Chembl1213492
9. 497833-27-9 (free Base)
10. (6-((diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate
11. (6-((diethylamino)methyl)naphthalen-2-yl)methyl(4-(hydroxycarbamoyl)phenyl)carbamate
12. [4-[(hydroxyamino)carbonyl]phenyl]carbamic Acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl Ester
13. Gavinostat
14. 4-[(hydroxyamino)carbonyl]phenyl]carbamic Acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl Ester
15. Unii-5p60f84fbh
16. {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate
17. Gavinostat;itf-2357
18. Gtpl7490
19. Schembl1555814
20. Chebi:94187
21. Dtxsid70198049
22. Bcp29856
23. Zinc3820616
24. Bdbm50105329
25. Cs-4727
26. Db12645
27. Ex-5958
28. [6-(diethylaminomethyl)-2-naphthyl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate
29. Ac-31380
30. Bcb04_000011
31. Hy-14842
32. Ec-000.2471
33. 833h279
34. A923985
35. Q426257
36. Gavinostat; Itf-2357; Itf2357; Itf 2357
37. Brd-k13810148-001-01-3
38. Carbamic Acid, (4-((hydroxyamino)carbonyl)phenyl)-, (6-((diethylamino)methyl)-2-naphthalenyl)methyl Ester
39. Qcm
Molecular Weight | 421.5 g/mol |
---|---|
Molecular Formula | C24H27N3O4 |
XLogP3 | 3.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 9 |
Exact Mass | 421.20015635 g/mol |
Monoisotopic Mass | 421.20015635 g/mol |
Topological Polar Surface Area | 90.9 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 575 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Juvenile idiopathic arthritis
ABOUT THIS PAGE
55
PharmaCompass offers a list of Givinostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Givinostat manufacturer or Givinostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Givinostat manufacturer or Givinostat supplier.
PharmaCompass also assists you with knowing the Givinostat API Price utilized in the formulation of products. Givinostat API Price is not always fixed or binding as the Givinostat Price is obtained through a variety of data sources. The Givinostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 497833-27-9 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 497833-27-9, including repackagers and relabelers. The FDA regulates 497833-27-9 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 497833-27-9 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 497833-27-9 supplier is an individual or a company that provides 497833-27-9 active pharmaceutical ingredient (API) or 497833-27-9 finished formulations upon request. The 497833-27-9 suppliers may include 497833-27-9 API manufacturers, exporters, distributors and traders.
497833-27-9 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 497833-27-9 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 497833-27-9 GMP manufacturer or 497833-27-9 GMP API supplier for your needs.
A 497833-27-9 CoA (Certificate of Analysis) is a formal document that attests to 497833-27-9's compliance with 497833-27-9 specifications and serves as a tool for batch-level quality control.
497833-27-9 CoA mostly includes findings from lab analyses of a specific batch. For each 497833-27-9 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
497833-27-9 may be tested according to a variety of international standards, such as European Pharmacopoeia (497833-27-9 EP), 497833-27-9 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (497833-27-9 USP).